Health Affairs December 12, 2019
Over the past week, there have been developments in both houses of Congress on drug pricing legislation. In the House of Representatives, the Democratic caucus is expected to pass H.R. 3, the Elijah Cummings Lower Drug Costs Now Act, which contains a series of far-reaching drug pricing reforms (pre-amendment summary here, pre-amendment text here). At the same time, the House Republican caucus introduced its own drug pricing bill, largely composed of smaller bipartisan elements (summary here, text here). In the Senate, the Finance Committee released updates to its drug pricing package (news summary here, text here), and the Health, Education, Labor, and Pensions (HELP) Committee reached a deal on surprise billing that includes a range of small bipartisan drug pricing...
Today's Sponsors
Today's Sponsor